Genotyping of Clinical Parameters in Age-Related Macular Degeneration

References

• Randolph SA. Age-related macular degeneration. Workplace Health Saf. 2014;62(8):352. doi:10.1177/216507991406200807
   PubMed Web of Science ®Google Scholar
• Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–e116. doi:10.1016/S2214-109X(13)70145-1
   PubMed Web of Science ®Google Scholar
• Zając-Pytrus HM, Pilecka A, Turno-Kręcicka A, et al. The dry form of Age-Related Macular Degeneration (AMD): the current concepts of pathogenesis and prospects for treatment. Adv Clin Exp Med. 2015;24(6):1099–1104. doi:10.17219/acem/27093
   PubMed Web of Science ®Google Scholar
• Baumal CR. Clinical applications of optical coherence tomography. Curr Opin Ophthalmol. 1999;10(3):182–188. doi:10.1097/00055735-199906000-00006
   PubMedGoogle Scholar
• Voo I, Mavrofrides EC, Puliafito CA. Clinical applications of optical coherence tomography for the diagnosis and management of macular diseases. Ophthalmol Clin North Am. 2004;17(1):21–31. doi:10.1016/j.ohc.2003.12.002
   PubMedGoogle Scholar
• Schmidt‐Erfurth UM, Richard G, Augustin A, et al. Guidance for the treatment of neovascular age‐related macular degeneration. Acta Ophthalmol Scand. 2007;85(5):486–494. doi:10.1111/j.1755-3768.2007.00979.x
   PubMedGoogle Scholar
• Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009;147(4):644–652. doi:10.1016/j.ajo.2008.10.005
   PubMed Web of Science ®Google Scholar
• Penha FM, Rosenfeld PJ, Gregori G, et al. Quantitative imaging of retinal pigment epithelial detachments using spectral-domain optical coherence tomography. Am J Ophthalmol. 2012;153(3):515–523. doi:10.1016/j.ajo.2011.08.031
   PubMed Web of Science ®Google Scholar
• Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58(3):353.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10(1):31. doi:10.1186/1471-2415-10-31
   PubMed Web of Science ®Google Scholar
• Tomany SC, Wang JJ, van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111(7):1280–1287. doi:10.1016/j.ophtha.2003.11.010
   PubMed Web of Science ®Google Scholar
• Zinkernagel MS, Zysset-Burri DC, Keller I, et al. Association of the intestinal microbiome with the development of neovascular age-related macular degeneration. Sci Rep. 2017;7(1):40826. doi:10.1038/srep40826
   PubMed Web of Science ®Google Scholar
• Zisimopoulos A, Klavdianou O, Theodossiadis P, et al. The role of the microbiome in age-related macular degeneration: a review of the literature. Ophthalmologica. 2021;244(3):173–178. doi:10.1159/000515026
   PubMed Web of Science ®Google Scholar
• Rudnicka AR, Kapetanakis VV, Jarrar Z, et al. Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis. Am J Ophthalmol. 2015;160(1):85–93. e3. doi:10.1016/j.ajo.2015.04.003
   PubMed Web of Science ®Google Scholar
• Sharma K, Singh R, Sharma SK, et al. Sleeping pattern and activities of daily living modulate protein expression in AMD. PLoS One. 2021;16(6):e0248523. doi:10.1371/journal.pone.0248523
   PubMed Web of Science ®Google Scholar
• Sharma K, Sharma NK, Singh R, et al. Exploring the role of VEGF in Indian age related macular degeneration. Ann Neurosci. 2015;22(4):232–237. doi:10.5214/ans.0972.7531.220408
   PubMedGoogle Scholar
• Sharma NK, Sharma K, Singh R, et al. CCL2 single nucleotide polymorphism of rs1024611 implicates prominence of inflammatory cascade by univariate modeling in Indian AMD. PLoS One. 2018;13(4):e0193423. doi:10.1371/journal.pone.0193423
   PubMed Web of Science ®Google Scholar
• Sharma K, Sharma NK, Singh R, et al. Gene networks determine predisposition to AMD. Genomics. 2021;113(1):514–522. doi:10.1016/j.ygeno.2020.09.044
   PubMed Web of Science ®Google Scholar
• Sharma NK, Sharma K, Gupta A, et al. Does toll-like receptor-3 (TLR-3) have any role in Indian AMD phenotype? Mol Cell Biochem. 2014;393(1–2):1–8. doi:10.1007/s11010-014-2040-4
   PubMed Web of Science ®Google Scholar
• Sharma K, Tyagi R, Singh R, et al. Serum levels of TIMP-3, LIPC, IER3, and SLC16A8 in CFH-negative AMD cases. J Cell Biochem. 2017;118(8):2087–2095. doi:10.1002/jcb.25837
   PubMed Web of Science ®Google Scholar
• Rajendran A, Dhoble P, Sundaresan P, et al. Genetic risk factors for late age-related macular degeneration in India. Br J Ophthalmol. 2018;102(9):1213–1217. doi:10.1136/bjophthalmol-2017-311384
   PubMed Web of Science ®Google Scholar
• Kan M, Weng X, Wang T, et al. No evidence of association between variant rs2075650 in lipid metabolism-related locus APOE/TOMM40 and advanced age-related macular degeneration in Han Chinese population. Exp Biol Med. 2015;240(2):230–234. doi:10.1177/1535370214553770
   Web of Science ®Google Scholar
• Wang Y-F, Han Y, Zhang R, Qin L, Wang MX, Ma L. CETP/LPL/LIPC gene polymorphisms and susceptibility to age-related macular degeneration. Sci Rep. 2015;5(1):1–13.
   Google Scholar
• Wang Y, Wang M, Zhang X, et al. The association between LIPC rs493258 polymorphism and the susceptibility to age-related macular degeneration. Int J Environ Res Public Health. 2016;13(10):1022. doi:10.3390/ijerph13101022
   PubMed Web of Science ®Google Scholar
• Qureshi IZ, Ambreen F. Serum APOE, leptin, CFH and HTRA1 levels in Pakistani age related macular degeneration patients. J Pak Med Assoc. 2017;67(6):852–857.
   PubMed Web of Science ®Google Scholar
• Battu P, Sharma K, Rain M, et al. Serum levels of ARMS2, COL8A1, RAD51B, and VEGF and their correlations in age-related macular degeneration. Curr Neurovasc Res. 2021;18(2):181–188. doi:10.2174/1567202618666210531130711
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107(12):2224–2232. doi:10.1016/s0161-6420(00)00409-7
   PubMed Web of Science ®Google Scholar
• Ritter M, Elledge J, Simader C, et al. Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres. Br J Ophthalmol. 2011;95(3):381–385. doi:10.1136/bjo.2009.175976
   PubMed Web of Science ®Google Scholar
• Sharma NK, Gupta A, Prabhakar S, et al. CC chemokine receptor-3 as new target for age-related macular degeneration. Gene. 2013;523(1):106–111. doi:10.1016/j.gene.2013.03.052
   PubMed Web of Science ®Google Scholar
• Anand A, Gupta PK, Sharma NK, et al. Soluble VEGFR1 (sVEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients. Eur J Neurol. 2012;19(5):788–792. doi:10.1111/j.1468-1331.2011.03548.x
   PubMed Web of Science ®Google Scholar
• Anand A, Sharma NK, Gupta A, et al. Single nucleotide polymorphisms in MCP-1 and its receptor are associated with the risk of age related macular degeneration. PLoS One. 2012;7(11):e49905. doi:10.1371/journal.pone.0049905
   PubMed Web of Science ®Google Scholar
• Gupta PK, Prabhakar S, Abburi C, Sharma NK, Anand A. Vascular endothelial growth factor-a and chemokine ligand (CCL2) genes are upregulated in peripheral blood mononuclear cells in Indian amyotrophic lateral sclerosis patients. J Neuroinflammation. 2011;8(1):1–6. doi:10.1186/1742-2094-8-1
   PubMed Web of Science ®Google Scholar
• Sharma NK, Gupta A, Prabhakar S, et al. Single nucleotide polymorphism and serum levels of VEGFR2 are associated with age related macular degeneration. Curr Neurovasc Res. 2012;9(4):256–265. doi:10.2174/156720212803530681
   PubMed Web of Science ®Google Scholar
• Sharma NK, Gupta A, Prabhakar S, et al. Association between CFH Y402H polymorphism and age related macular degeneration in North Indian cohort. PLoS One. 2013;8(7):e70193. doi:10.1371/journal.pone.0070193
   PubMed Web of Science ®Google Scholar
• Sharma NK, Prabhakar S, Gupta A, et al. New biomarker for neovascular age-related macular degeneration: eotaxin-2. DNA Cell Biol. 2012;31(11):1618–1627. doi:10.1089/dna.2012.1786
   PubMed Web of Science ®Google Scholar
• Vinish M, Prabhakar S, Khullar M, et al. Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India. J Neurol Neurosurg Psychiatry. 2010;81(2):166–170. doi:10.1136/jnnp.2008.157255
   PubMed Web of Science ®Google Scholar
• Anand A, Saraf MK, Prabhakar S. Sustained inhibition of brotizolam induced anterograde amnesia by norharmane and retrograde amnesia by l-glutamic acid in mice. Behav Brain Res. 2007;182(1):12–20. doi:10.1016/j.bbr.2007.04.022
   PubMed Web of Science ®Google Scholar
• Singh T, Prabhakar S, Gupta A, et al. Recruitment of stem cells into the injured retina after laser injury. Stem Cells Dev. 2012;21(3):448–454. doi:10.1089/scd.2011.0002
   PubMed Web of Science ®Google Scholar
• Anand A, Saraf MK, Prabhakar S. Antiamnesic effect of B. monniera on L-NNA induced amnesia involves calmodulin. Neurochem Res. 2010;35(8):1172–1181. doi:10.1007/s11064-010-0171-x
   PubMed Web of Science ®Google Scholar
• Yasuda M, Kiyohara Y, Hata Y, et al. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. Ophthalmology. 2009;116(11):2135–2140. doi:10.1016/j.ophtha.2009.04.017
   PubMed Web of Science ®Google Scholar
• Horie-Inoue K, Inoue S. Genomic aspects of age-related macular degeneration. Biochem Biophys Res Commun. 2014;452(2):263–275. doi:10.1016/j.bbrc.2014.08.013
   PubMed Web of Science ®Google Scholar
• Seddon JM, Reynolds R, Rosner B. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis. 2010;16:2412.
   PubMed Web of Science ®Google Scholar
• Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143(4):566–583. e2. doi:10.1016/j.ajo.2007.01.028
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ. Optical coherence tomography and the development of antiangiogenic therapies in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2016;57(9):OCT14–OCT26. doi:10.1167/iovs.16-19969
   PubMed Web of Science ®Google Scholar
• Karacorlu M, Sayman Muslubas I, Arf S, et al. Membrane patterns in eyes with choroidal neovascularization on optical coherence tomography angiography. Eye. 2019;33(8):1280–1289. doi:10.1038/s41433-019-0415-1
   PubMed Web of Science ®Google Scholar
• Cascella R, Strafella C, Caputo V, et al. Towards the application of precision medicine in age-related macular degeneration. Prog Retin Eye Res. 2018;63:132–146. doi:10.1016/j.preteyeres.2017.11.004
   PubMed Web of Science ®Google Scholar
• Myers CE, Klein BEK, Gangnon R, et al. Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2014;121(10):1949–1955. doi:10.1016/j.ophtha.2014.04.040
   PubMed Web of Science ®Google Scholar
• Rasoulinejad SA, Zarghami A, Hosseini SR, et al. Prevalence of age-related macular degeneration among the elderly. Casp J Intern Med. 2015;6(3):141.
   PubMed Web of Science ®Google Scholar
• Rim TH, Cheng C-Y, Kim DW, et al. A nationwide cohort study of cigarette smoking and risk of neovascular age-related macular degeneration in East Asian men. Br J Ophthalmol. 2017;101(10):1367–1373. doi:10.1136/bjophthalmol-2016-309952
   PubMed Web of Science ®Google Scholar
• Vassilev ZP, Ruigomez A, Soriano-Gabarro M, et al. Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population. Invest Ophthalmol Vis Sci. 2015;56(3):1585–1592. doi:10.1167/iovs.14-16271
   PubMed Web of Science ®Google Scholar
• Rohrer B, Frazer-Abel A, Leonard A, et al. Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent. Mol Vis. 2019;25:79–92.
   PubMed Web of Science ®Google Scholar
• Lee CS, Tyring AJ, Wu Y, et al. Generating retinal flow maps from structural optical coherence tomography with artificial intelligence. Sci Rep. 2019;9(1):5694. doi:10.1038/s41598-019-42042-y
   PubMed Web of Science ®Google Scholar
• Sharma K, Battu P, Singh R, Sharma SK, Anand A. Modulated anti-VEGF therapy under the influence of lipid metabolizing proteins in Age related macular degeneration: a pilot study. Sci Rep. 2022;12(1):714. doi:10.1038/s41598-021-04269-6
   PubMed Web of Science ®Google Scholar